Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
Table 2
Multivariate analysis in the overall cohort of patients receiving chemotherapy (cohort 1 + cohort 2, n = 451) with neutrophil-to-lymphocyte ratio as a continuous variable.